The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site
- PMID: 20122159
- PMCID: PMC2831009
- DOI: 10.1186/1742-4690-7-6
The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site
Abstract
Background: The p51 subunit of the HIV-1 reverse transcriptase (RT) p66/p51 heterodimer arises from proteolytic cleavage of the RT p66 subunit C-terminal ribonuclease H (RNH) domain during virus maturation. Our previous work showed that mutations in the RT p51 downward arrowRNH cleavage site resulted in virus with defects in proteolytic processing of RT and significantly attenuated infectivity. In some cases, virus fitness was restored after repeated passage of mutant viruses, due to reversion of the mutated sequences to wild-type. However, in one case, the recovered virus retained the mutated p51 downward arrowRNH cleavage site but also developed an additional mutation, T477A, distal to the cleavage site. In this study we have characterized in detail the impact of the T477A mutation on intravirion processing of RT.
Results: While the T477A mutation arose during serial passage only with the F440V mutant background, introduction of this substitution into a variety of RT p51 downward arrowRNH cleavage site lethal mutant backgrounds was able to restore substantial infectivity and normal RT processing to these mutants. T477A had no phenotypic effect on wild-type HIV-1. We also evaluated the impact of T477A on the kinetics of intravirion Gag-Pol polyprotein processing of p51 downward arrowRNH cleavage site mutants using the protease inhibitor ritonavir. Early processing intermediates accumulated in p51 downward arrowRNH cleavage site mutant viruses, whereas introduction of T477A promoted the completion of processing and formation of the fully processed RT p66/p51 heterodimer.
Conclusions: This work highlights the extraordinary plasticity of HIV-1 in adapting to seemingly lethal mutations that prevent RT heterodimer formation during virion polyprotein maturation. The ability of T477A to restore RT heterodimer formation and thus intravirion stability of the enzyme may arise from increased conformation flexibility in the RT p51 downward arrowRNH cleavage site region, due to loss of a hydrogen bond associated with the normal threonine residue, thereby enabling proteolytic cleavage near the normal RT p51 downward arrowRNH cleavage site.
Figures




Similar articles
-
Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.J Virol. 2005 Sep;79(18):11952-61. doi: 10.1128/JVI.79.18.11952-11961.2005. J Virol. 2005. PMID: 16140771 Free PMC article.
-
Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.Int J Biochem Cell Biol. 2004 Sep;36(9):1836-47. doi: 10.1016/j.biocel.2004.02.020. Int J Biochem Cell Biol. 2004. PMID: 15183348
-
Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.Proteins. 2015 Aug;83(8):1526-38. doi: 10.1002/prot.24843. Epub 2015 Jul 1. Proteins. 2015. PMID: 26061827 Free PMC article.
-
HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.J Mol Biol. 2007 Sep 14;372(2):369-81. doi: 10.1016/j.jmb.2007.06.073. Epub 2007 Jul 3. J Mol Biol. 2007. PMID: 17651754 Free PMC article.
-
HIV-1 Reverse Transcriptase: A Metamorphic Protein with Three Stable States.Structure. 2019 Mar 5;27(3):420-426. doi: 10.1016/j.str.2018.11.011. Epub 2019 Jan 10. Structure. 2019. PMID: 30639227 Free PMC article. Review.
Cited by
-
Effect of Lysyl-tRNA Synthetase on the Maturation of HIV-1 Reverse Transcriptase.ACS Omega. 2020 Jun 30;5(27):16619-16627. doi: 10.1021/acsomega.0c01449. eCollection 2020 Jul 14. ACS Omega. 2020. PMID: 32685828 Free PMC article.
-
Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.J Antimicrob Chemother. 2022 Feb 2;77(2):474-482. doi: 10.1093/jac/dkab385. J Antimicrob Chemother. 2022. PMID: 34741609 Free PMC article.
-
Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmission.Drug Deliv Transl Res. 2011 Jun 1;1(3):209-222. doi: 10.1007/s13346-011-0022-6. Drug Deliv Transl Res. 2011. PMID: 22708075 Free PMC article.
-
The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.J Virol. 2015 Jan 15;89(2):1286-97. doi: 10.1128/JVI.02312-14. Epub 2014 Nov 12. J Virol. 2015. PMID: 25392207 Free PMC article.
-
Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability.Viruses. 2016 Sep 27;8(10):260. doi: 10.3390/v8100260. Viruses. 2016. PMID: 27690082 Free PMC article. Review.
References
-
- Chattopadhyay D, Evans DB, Deibel MR Jr. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease. J Biol Chem. 1992;267(20):14227–32. - PubMed
-
- Fan N, Rank KB, Leone JW. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases. J Biol Chem. 1995;270(22):13573–9. - PubMed
-
- Hostomska Z, Matthews DA, Davies JF, Nodes BR, Hostomsky Z. Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem. 1991;266(22):14697–702. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous